Component: (Network and Table) | |
---|---|
Network | 00400 - Statement - Statements of Cash Flows (http://www.ocutx.com/role/StatementStatementsOfCashFlows) |
Table | (Implied) |
Reporting Entity [Axis] | 0001393434 (http://www.sec.gov/CIK) |
Statement of Cash Flows [Abstract] | Period [Axis] | ||
---|---|---|---|
2016-01-01 - 2016-12-31 | 2015-01-01 - 2015-12-31 | 2014-01-01 - 2014-12-31 | |
Statement of Cash Flows [Abstract] | |||
Cash flows from operating activities: | |||
Net loss | (44,703,000) | (39,748,000) | (28,648,000) |
Adjustments to reconcile net loss to net cash used in operating activities | |||
Stock-based compensation expense | |||
Licensing and consultant fees paid in common stock | |||
Non-cash interest expense | |||
Depreciation and amortization expense | |||
Revaluation of preferred stock warrants | |||
Loss on extinguishment of debt | |||
(Gain)/loss on disposal of property and equipment | ( | ||
Purchase of premium on marketable securities | ( | ( | ( |
Amortization of premium on marketable securities | |||
Changes in operating assets and liabilities: | |||
Accounts receivable from related party | |||
Accounts receivable | ( | ( | |
Prepaid expenses and other current assets | ( | ( | |
Inventory | ( | ( | |
Accounts payable | ( | ||
Accrued expenses and deferred rent | |||
Deferred revenue | ( | ( | ( |
Net cash used in operating activities | ( | ( | ( |
Cash flows from investing activities: | |||
Purchases of property and equipment | ( | ( | ( |
Proceeds from sale of property and equipment | |||
Change in restricted cash | ( | ||
Purchases of marketable securities | ( | ( | ( |
Proceeds from maturities of marketable securities | |||
Net cash provided by (used in) investing activities | ( | ( | |
Cash flows from financing activities: | |||
Proceeds from issuance of notes payable and preferred stock warrants | |||
Proceeds from exercise of stock options | |||
Proceeds from issuance of common stock pursuant to employee stock purchase plan | |||
Proceeds from issuance of public offering, net | |||
Payments of offering costs | ( | ( | ( |
Payments of insurance costs financed by a third-party | ( | ( | ( |
Repayment of notes payable | ( | ( | |
Net cash provided by financing activities | |||
Net increase (decrease) in cash and cash equivalents | ( | ||
Cash and cash equivalents at beginning of period | 30,784,000 | ||
Cash and cash equivalents at end of period | 32,936,000 | 30,784,000 | 37,393,000 |
Supplemental disclosure of cash flow information: | |||
Cash paid for interest | |||
Supplemental disclosure of non-cash investing and financing activities: | |||
Accretion of redeemable convertible preferred stock to redemption value | 11,000 | ||
Conversion of redeemable convertible preferred stock to common stock | |||
Conversion of warrants for redeemable convertible preferred stock to warrants for common stock | |||
Additions to property and equipment included in accounts payable and accrued expenses | |||
Insurance premium financed by a third party | |||
Initial public offering costs included in accounts payable |